This MR study suggested a potential role of increasing genus Roseburia and family Bifidobacteriaceae abundance, as well as stearidonate (18:4n3), in mitigating inflammation or infectious risks, which could reduce CRP, SAA1, or GlycA levels, pneumonia, or UTI risk. This evidence concerns the gene SAA1 and bacterial urinary tract infection.